Bayer Financial Statements From 2010 to 2024
| BAYA Stock | EUR 4.80 0.14 2.83% |
Check Bayer Aktiengesellscha financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bayer Aktiengesellscha's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bayer financial statements analysis is a perfect complement when working with Bayer Aktiengesellscha Valuation or Volatility modules.
Bayer |
Bayer Aktiengesellschaft Company Shares Outstanding Analysis
Bayer Aktiengesellscha's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Bayer Aktiengesellscha Shares Outstanding | 3.93 B |
Most of Bayer Aktiengesellscha's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayer Aktiengesellschaft is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Bayer Aktiengesellschaft has 3.93 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The shares outstanding for all Germany stocks is significantly lower than that of the firm.
Bayer Aktiengesellschaft Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bayer Aktiengesellscha's current stock value. Our valuation model uses many indicators to compare Bayer Aktiengesellscha value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bayer Aktiengesellscha competition to find correlations between indicators driving Bayer Aktiengesellscha's intrinsic value. More Info.Bayer Aktiengesellschaft is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bayer Aktiengesellschaft is roughly 2.26 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bayer Aktiengesellscha's earnings, one of the primary drivers of an investment's value.About Bayer Aktiengesellscha Financial Statements
Bayer Aktiengesellscha stakeholders use historical fundamental indicators, such as Bayer Aktiengesellscha's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bayer Aktiengesellscha investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bayer Aktiengesellscha's assets and liabilities are reflected in the revenues and expenses on Bayer Aktiengesellscha's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bayer Aktiengesellschaft. Please read more on our technical analysis and fundamental analysis pages.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER ADR is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in Bayer Stock
Bayer Aktiengesellscha financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer Aktiengesellscha security.